Post-operative serum sialyltransferase levels and prognosis in breast cancer.
Serum sialyltransferase (SST) activity was measured 10 days after mastectomy in 153 patients with operable breast cancer. Enzyme activity declined with time in storage (1-42 months). After correction for loss of activity in storage, patients with SST activity below the median value had a longer disease-free interval (DFI) than those with SST activity above the median, and this difference remained when patients were stratified by axillary nodal status, tumor size, and tumor grade. Survival was longer in patients with low SST activity. Post-operative elevation of SST indicates a poor prognosis in patients with operable breast cancer.
D001943:Breast Neoplasms / Q000201:enzymology* / Q000401:mortality / Q000601:surgery; D005260:Female; D006801:Humans; D008408:Mastectomy; D011184:Postoperative Period; D011379:Prognosis; D012799:Sialyltransferases / Q000097:blood*; D014166:Transferases / Q000097:blood*; D000094802:beta-D-Galactoside alpha 2-6-Sialyltransferase
D014166:Transferases; D012799:Sialyltransferases; D000094802:beta-D-Galactoside alpha 2-6-Sialyltransferase